Actinium Pharmaceuticals Inc. (ATNM) is priced at $10.24 after the most recent trading session. At the very opening of the session, the stock price was $11.80 and reached a high price of $11.99, prior to closing the session it reached the value of $11.78. The stock touched a low price of $9.31.Recently in News on November 3, 2022, Actinium Announces Positive 1-Year and 2-Year Overall Survival Data for Patients with Relapsed or Refractory AML in Phase 1 Actimab-A CLAG-M Combination Trial. 53% 1-year Overall Survival and 32% 2-year Overall Survival are approximately double outcomes with current approaches. You can read further details here
Actinium Pharmaceuticals Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $15.12 on 11/03/22, with the lowest value was $4.41 for the same time period, recorded on 03/15/22.
Actinium Pharmaceuticals Inc. (ATNM) full year performance was 38.01%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Actinium Pharmaceuticals Inc. shares are logging -32.28% during the 52-week period from high price, and 132.20% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $4.41 and $15.12.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1516049 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Actinium Pharmaceuticals Inc. (ATNM) recorded performance in the market was 70.38%, having the revenues showcasing 65.70% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 260.71M, as it employees total of 32 workers.
Analysts verdict on Actinium Pharmaceuticals Inc. (ATNM)
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 7.55, with a change in the price was noted +5.28. In a similar fashion, Actinium Pharmaceuticals Inc. posted a movement of +106.45% for the period of last 100 days, recording 361,680 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ATNM is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Actinium Pharmaceuticals Inc. (ATNM): Technical Analysis
Raw Stochastic average of Actinium Pharmaceuticals Inc. in the period of last 50 days is set at 41.49%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 31.94%. In the last 20 days, the company’s Stochastic %K was 49.57% and its Stochastic %D was recorded 56.43%.
Let’s take a glance in the erstwhile performances of Actinium Pharmaceuticals Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 70.38%. Additionally, trading for the stock in the period of the last six months notably improved by 83.84%, alongside a boost of 38.01% for the period of the last 12 months. The shares increased approximately by -16.54% in the 7-day charts and went down by 40.47% in the period of the last 30 days. Common stock shares were driven by 65.70% during last recorded quarter.